Neuropace, Inc. (NPCE) analyst actions
Rating and price-target actions on NPCE in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the NPCE overview →
3 measured NPCE analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook | Press release | -1.79% | -9.88% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against NeuroPace, Inc. (NPCE) And Encourages Shareholders to Reach Out | Press release | -0.39% | -4.34% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against NeuroPace, Inc. (NPCE) And Encourages Stockholders to Reach Out | Press release | +1.42% | +7.12% |
Keep exploring
More NPCE: earnings → · SEC filings → · NPCE overview →